Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy

INTRODUCTION: Extended adjuvant endocrine therapy for breast cancer with aromatase inhibitors may potentially alter the lipid profile of postmenopausal patients and thus increase the risk of developing cardiovascular disease. In this study, a subprotocol of the ATENA (Adjuvant post-Tamoxifen Exemest...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Markopoulos, Christos, Dafni, Urania, Misitzis, John, Zobolas, Vasilios, Tzoracoleftherakis, Evagelos, Koukouras, Dimitrios, Xepapadakis, Grigorios, Papadiamantis, John, Venizelos, Basileios, Antonopoulou, Zoh, Gogas, Helen
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2009
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2716503/
https://ncbi.nlm.nih.gov/pubmed/19531217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr2320
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados